Want to see HK:1228 full AI Analyst Report?
CANbridge Pharmaceuticals Inc. (1228) Revenue
CANbridge Pharmaceuticals Inc. Revenue
CANbridge Pharmaceuticals Inc. had a revenue of 13.97M in the quarter ending Jun 30, 2026, with 0.00%. This bring the company's revenue in the last twelve months to 55.67M, Increased 5.39%. In the fiscal year ending Dec 31, 2025, CANbridge Pharmaceuticals Inc. had annual revenue of 49.98M with -41.27% growth.
- Revenue (ttm)
- 55.67M
- Revenue Growth
- -8.00%
- P/S Ratio
- 21.17
- Revenue/Employee
- HKD 1,281,615
- Employees
- 39
- Market Cap
- HKD 1.06B
Revenue Chart
CANbridge Pharmaceuticals Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 49.98M | -35.12M | -41.27% |
| Dec 31, 2024 | 85.10M | -17.77M | -17.27% |
| Dec 31, 2023 | 102.87M | 23.90M | 30.26% |
| Dec 31, 2022 | 78.97M | 47.81M | 153.43% |
| Dec 31, 2021 | 31.16M | 19.13M | 158.98% |
| Dec 31, 2020 | 12.03M | 10.56M | 719.06% |
| Dec 31, 2019 | 1.47M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.